Medication Labeling and Storage Deficiencies
Summary
Drugs and biologicals were not labeled and stored in accordance with accepted professional principles when an eye drop medication for a resident with glaucoma was found on the medication cart with an open date that exceeded the manufacturer’s discard timeframe. The resident’s record showed an order for Latanoprost ophthalmic solution for glaucoma, and the MAR showed the medication was administered during the period reviewed. During the medication cart observation, the eye drops were present on the First Floor Team Two medication cart with an open date of 12/29/2025. The DON reviewed the manufacturer’s instructions and confirmed the medication should have been discarded after six weeks of opening, and that the resident received the medication beyond that timeframe. A second labeling issue involved a resident with hypotension who had an order for Midodrine 5 mg twice daily with instructions to hold the medication if systolic blood pressure was greater than 120 mmHg. During a medication pass, the resident’s blood pressure was 101/62 mmHg and the LVN administered Midodrine. Afterward, the Midodrine bubble pack was reviewed and the label stated to hold the medication if systolic blood pressure was less than 120 mmHg, which did not match the physician’s order in the eMAR. The nurse acknowledged the discrepancy and stated she followed the eMAR order, while RN 1 stated the inaccurate label was a lapse by the pharmacy and could potentially cause a medication error. The facility also failed to ensure prescription labels for medications with black box warnings were identified as such for four sampled residents. One resident with severe cognitive impairment and no decision-making capacity had Sertraline without a black box warning on the bubble pack or MAR. Another resident with Alzheimer’s disease, major depressive disorder, and bipolar disorder had Remeron without a black box warning on the bubble pack or MAR. A third resident with Alzheimer’s disease, depression, and a history of falls had Lexapro without a black box warning on the bubble pack or MAR. A fourth resident with severe cognitive impairment and dependence for many ADLs had Zyprexa and Mirtazapine bubble packs without black box warning labels. The pharmacist verified that Zyprexa and Mirtazapine carried black box warnings, and facility policy stated medications bearing a black box warning must be identified on prescription labels.
Penalty
Resources
Below are regulatory guidelines relevant to this citation:
Trusted data from CMS and state health departments
Every citation, penalty and Plan of Correction is sourced from public CMS records (latest release July 29, 2026) and official state health department websites — never guesswork.
In your survey window? See what surveyors are citing.
The Survey-Prep Report maps your facility's risk from 12 months of CMS and state citation data — what's being cited around you and what to check first. $129 one-time.